0
Article Tier 2 Sign in to save

Microplastic and Nanoplastic Exposure and Cardiovascular Disease: A Narrative Review of Mechanistic Evidence, Candidate Epigenetic Pathways and Current Evidence Gaps

AI summary Read the abstract

This review paper summarizes existing research on whether microplastics and nanoplastics affect heart and blood vessel health. Studies in cells, mice and fish found signs of oxidative stress, inflammation and altered DNA activity after plastic particle exposure, and one human study linked plastics found in neck artery plaque to higher rates of heart attack, stroke or death. The authors conclude a clear biological pathway remains unproven.

Microplastics (MPs; particles 1 μm–5 mm) and nanoplastics (NPs; <1 μm) are ubiquitous environmental contaminants and have been detected in human blood, placenta, lung tissue and carotid atherosclerotic plaque. They do not constitute a uniform exposure: polymer composition, particle size, shape, surface chemistry and charge, chemical additives and leachates, adsorbed co-contaminants and weathering state all vary and may each modify biological effects. Experimental studies, most of which have used pristine polystyrene spheres, link MP/NP exposure to oxidative stress, mitochondrial dysfunction and vascular inflammation. Epigenetic regulation has been proposed as a mechanism by which a transient exposure could produce persistent cardiovascular effects, but the strength of the supporting evidence has not been systematically appraised. To summarise the experimental, translational and human evidence concerning the cardiovascular effects of MP/NP exposure, and to appraise candidate epigenetic pathways — DNA methylation, RNA and histone modifications, and non-coding RNAs — while explicitly separating mechanisms demonstrated after defined MP/NP exposure from those extrapolated from general cardiovascular biology. In cultured cells and rodent models, polystyrene particles of approximately 1–10 μm induce endothelial activation, oxidative stress, mitochondrial dysfunction, and cardiac hypertrophic and fibrotic remodelling. Direct evidence that MP/NP exposure alters epigenetic marks derives mainly from fish studies — global DNA hypomethylation on re-exposure in zebrafish after early-life exposure to 9.5–11.5 μm polystyrene at 50 mg/L, and sex-dependent liver methylome changes in fathead minnow exposed to 150–500 μm polyethylene at 100–2000 particles/L — together with one mouse study reporting altered cardiac N6-methyladenosine (m6A) RNA methylation after chronic polystyrene exposure. No study identified in this review measured histone modifications, long non-coding RNAs or circular RNAs in cardiovascular tissue after MP/NP exposure; these links remain hypothetical extensions of general cardiovascular epigenetics. In humans, polyethylene (58.4% of plaques) and polyvinyl chloride (12.1%) detected in carotid plaque were associated with a higher composite rate of myocardial infarction, stroke or death (hazard ratio 4.53, 95% CI 2.00–10.27) in a single observational cohort of 257 patients, in which epigenetic markers were not assessed. An epigenetically mediated pathway from MP/NP exposure to cardiovascular injury is biologically plausible but largely unproven, and existing findings cannot be generalised across polymer types, particle sizes or dose ranges. Standardised particle characterisation, environmentally relevant exposure models and longitudinal human cohorts combining exposure assessment with multi-omic cardiovascular phenotyping are required before epigenetic dysregulation can be regarded as an established mechanism of plastic-related cardiovascular disease.

More Papers Like This

Article Tier 2

Microplastics and Nanoplastics in Cardiovascular Disease

AI summary Read the abstract

This review summarizes existing research on tiny plastic particles called microplastics and nanoplastics and their possible links to heart and blood vessel disease. It covers how these particles may enter the bloodstream, studies finding plastic particles in human artery plaques, and possible biological effects like inflammation and blood vessel damage reported in human, animal and lab studies.

Clinical Trial Tier 1

Microplastic and Nanoplastic Contamination as a Novel Cardiovascular Risk Factor: A Narrative Review of Pathophysiological Mechanisms and Public Health Consequences

AI summary Read the abstract

This review pulls together existing research on tiny plastic particles found in our blood, organs, and even artery plaque. One study found people with these plastics in their artery plaque had a much higher risk of heart attack, stroke, or death. Scientists think the plastics may cause harmful inflammation and cell damage, though more research is needed to confirm this causes heart disease.

Article Tier 2

Microplastics, Nanoplastics, and the Cardiovascular Exposome: Emerging Evidence for Vascular Deposition, Thrombotic Pathways, and Cardiovascular Risk

AI summary Read the abstract

This review pulls together existing studies on tiny plastic particles found in blood vessels and artery plaque, some of which link their presence to higher rates of heart attack, stroke, and death. However, these studies show a connection, not proof that plastics cause these problems. Scientists say more research is needed before doctors should test for plastics or change how they treat heart disease.

Article Tier 2

Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links

AI summary Read the abstract

This review summarizes growing evidence linking micro- and nanoplastic exposure to cardiovascular disease, including increased blood pressure, blood vessel inflammation, and heart muscle damage observed in animal studies. Human population studies also show that people exposed to more plastics face higher rates of hypertension and heart attacks, though researchers are still working to understand the exact biological mechanisms involved.

Article Tier 2

Nanoplastics and Cardiovascular Health: A Review of Environmental Exposure, Biological Mechanisms and GeoHealth Implications

AI summary Read the abstract

This review paper summarizes existing research on tiny plastic particles called nanoplastics and heart health. It reports that studies have found plastic particles in human blood, lungs, placenta, blood vessels, heart tissue and arterial plaque, and lab experiments suggest possible ways these particles could affect cells, though causation has not been established.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper